论文部分内容阅读
用人工合成的GOR肽与BSA交联后包被反应板，作为捕获抗原，建立了检测GOR抗体的间接ELISA。共检测临床各类病人278例，正常供血员48名。结果慢性丙肝患者抗GOR阳性检出率为60．0％（36／60），血透患者为43．6％（17／39），白血病患者为500％（6／12），甲亢患者为40．4％（19／47）。对抗ot）R抗体阳性的意义进行了分析。
After the synthetic GOR peptide was cross-linked with BSA, the reaction plate was coated and used as capture antigen to establish an indirect ELISA for the detection of GOR antibodies. A total of 278 cases of various types of clinical testing, 48 normal blood donors. Results The positive rate of anti-GOR in patients with chronic hepatitis C was 60.0% (36/60), that of hemodialysis patients was 43.6% (17/39), that of leukemia patients was 500% (6/12), and that of patients with hyperthyroidism was 40% .4% (19/47). The anti-ot) R antibody positive significance was analyzed.